XKR4
XK-related protein 4
Also known as: KIAA1889, XKR4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5GH76
- Gene
- XKR4
- Ensembl
- ENSG00000206579
- Chromosome
- 8
- Canonical length
- 650 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoli,Golgi apparatus,Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables phospholipid scramblase activity. Involved in phosphatidylserine exposure on apoptotic cell surface. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
650 residues, UniProt reviewed canonical sequence.
>Q5GH76|XKR4
1 MAAKSDGRLK MKKSSDVAFT PLQNSDHSGS VQGLAPGLPS GSGAEDEEAA GGGCCPDGGG
61 CSRCCCCCAG SGGSAGSGGS GGVAGPGGGG AGSAALCLRL GREQRRYSLW DCLWILAAVA
121 VYFADVGTDV WLAVDYYLRG QRWWFGLTLF FVVLGSLSVQ VFSFRWFVHD FSTEDSATAA
181 AASSCPQPGA DCKTVVGGGS AAGEGEARPS TPQRQASNAS KSNIAAANSG SNSSGATRAS
241 GKHRSASCSF CIWLLQSLIH ILQLGQIWRY FHTIYLGIRS RQSGENDRWR FYWKMVYEYA
301 DVSMLHLLAT FLESAPQLVL QLCIIVQTHS LQALQGFTAA ASLVSLAWAL ASYQKALRDS
361 RDDKKPISYM AVIIQFCWHF FTIAARVITF ALFASVFQLY FGIFIVLHWC IMTFWIVHCE
421 TEFCITKWEE IVFDMVVGII YIFSWFNVKE GRTRCRLFIY YFVILLENTA LSALWYLYKA
481 PQIADAFAIP ALCVVFSSFL TGVVFMLMYY AFFHPNGPRF GQSPSCACED PAAAFTLPPD
541 VATSTLRSIS NNRSVVSDRD QKFAERDGCV PVFQVRPTAP STPSSRPPRI EESVIKIDLF
601 RNRYPAWERH VLDRSLRKAI LAFECSPSPP RLQYKDDALI QERLEYETTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against XKR4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 2.7 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 2.7 nTPM
- colon: 1.7 nTPM
- hypothalamus: 1 nTPM
- amygdala: 0.9 nTPM
- basal ganglia: 0.8 nTPM
- cerebellum: 0.8 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 1,033 nCPM
- schwann cells: 799 nCPM
- lactotrophs: 776 nCPM
- brain inhibitory neurons: 763 nCPM
- retinal amacrine cells: 624 nCPM
- gonadotrophs: 616 nCPM
Immune cell
- basophil: 0.4 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 32 nTPM
- basal ganglia: 32 nTPM
- thalamus: 27 nTPM
- amygdala: 27 nTPM
- hypothalamus: 20 nTPM
- white matter: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.64
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process involved in development
- engulfment of apoptotic cell
- phosphatidylserine exposure on apoptotic cell surface
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of XKR4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads XKR4 as an antibody target. Whether an autoantibody or antibody against XKR4 could matter depends on whether native XKR4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
XKR4 is annotated at the cell surface, where native XKR4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label XKR4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...